Home / Recalls / Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) / D-0480-2025

D-0480-2025 Class II Ongoing

Recalled by Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) — Englewood, CO

Recall Details

Product Type
Drugs
Report Date
July 2, 2025
Initiation Date
May 21, 2025
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
164 syringes

Product Description

Semaglutide, 5 mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112

Reason for Recall

Lack of Assurance of Sterility

Distribution Pattern

USA Nationwide

Code Information

Lot #: C03035J, Exp 7/3/2025, H202959, exp 7/6/2025; AB20N110720 , exp 7/7/2025 ; AB60N1121, exp 7/7/2025; PRX022225-1 , exp 8/24/2025 ; U122024 , exp 10/26/2025

Other recalls by Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)

  • D-0478-2025 Class II — Nicotinamide adenine dinucleotide (NAD+): 100mg/mL, pre-filled syringe, Thrive H (May 21, 2025)
  • D-0476-2025 Class II — LL Bioboost Injectable, Each 1mL contains Methionine 25 mg, Inositol 50 mg, Chol (May 21, 2025)
  • D-0481-2025 Class II — Semaglutide/Cyanocobalamin Injectable, 5mg/1mg/mL, pre-filled syringe, Thrive He (May 21, 2025)
  • D-0484-2025 Class II — Tirzepatide Injections, 30mg/mL, pre-filled syringe, Thrive Health Solutions, 88 (May 21, 2025)
  • D-0486-2025 Class II — Tirzepatide/Cyanocobalamin Injectable, 30mg/1mg/mL (15mg/0.5mg/0.5mL), pre-fille (May 21, 2025)
  • D-0482-2025 Class II — Tirzepatide Injections, 10mg/mL, pre-filled syringe, Thrive Health Solutions, 88 (May 21, 2025)
  • D-0474-2025 Class II — Methylcobalamin Injectable, 10mg/mL, pre-filled syringe, Thrive Health Solutions (May 21, 2025)
  • D-0477-2025 Class II — LX Bioboost Plus, (Each 1mL contains Methionine 25 mg, Inositol 50 mg, Choline C (May 21, 2025)
  • D-0475-2025 Class II — CJC-1295 Injectable, 6mg/15mg, pre-filled syringe, Thrive Health Solutions, 88 I (May 21, 2025)
  • D-0483-2025 Class II — Tirzepatide Injections, 20mg/mL, pre-filled syringe, Thrive Health Solutions, 88 (May 21, 2025)